From: Thyroid disease and cancer in kidney transplantation: a single-center analysis
With nodule (n=204) | Without nodule (n=556) | P | |
---|---|---|---|
Male (%) | 48% | 47% | Ns |
Living/Deceased | 40/164 | 60/494 | Ns |
Age (years) | 48 ±12.3 | 54 ±10.5 | < 0.04 |
Cause of ESRD (n,%) | |||
Glomerulonephritis | 95 (46.6) | 265 (47.6) | Ns |
Polycystic Kidney Disease | 40 (19.7) | 87 (15.7) | Ns |
Diabetes | 30 (14.7) | 60 (10.8) | Ns |
Other causes | 39 (19.1) | 144 (25.9) | Ns |
Waiting list (months) | 21 ±10.4 | 18.2 ±16.4 | Ns |
Pretransplant dialysis | 32 ±16.3 | 29 ±22.3 | < 0.05 |
Donor age | 55.6 ± 15.1 | 54.2 ±18.1 | Ns |
Immunosuppression (n, %) | |||
Induction | 60 (29.4) | 160 (28.2) | Ns |
TAC+MPA+Ster | 170 (83.3) | 470 (83) | Ns |
CYA+MPA+Ster | 20 (9.8) | 60 (10.6) | Ns |
Eve+MPA+Ster | 24 (11.7) | 36 (6.3) | Ns |
BMI (KG/m2) | 25 ±4.7 | 26.1 ±3.9 | Ns |
Serum Creatinine (mg/dL) | 1.53 ±0.7 | 1.49 ±0.6 | Ns |